Oxazole

Oxazole

SCHEMBL1743576

c1cocn1.c1cocn1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxazole SCHEMBL29728171 1.00
Oxazole SCHEMBL14 1.00
Oxazole SCHEMBL983076 0.96
Oxazole SCHEMBL7538737 0.96
Oxazole SCHEMBL645202 0.96
Oxazole SCHEMBL3864385 0.96
Oxazole SCHEMBL9452923 0.96
Oxazole SCHEMBL1128503 0.96
Oxazole SCHEMBL5199619 0.96
Oxazole SCHEMBL6315939 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115583958-A Synthesis method of dihydrothia (oxa) zole [3',2':1,5] dihydroimidazole [4,5-b ] piperidine derivative 河南师范大学 2023-01-10 CN claimed
CN-115583958-A Synthesis method of dihydrothia (oxa) zole [3',2':1,5] dihydroimidazole [4,5-b ] piperidine derivative 河南师范大学 2023-01-10 CN disclosed
CN-110998889-B Organic electroluminescent element containing compound having benzoxazole ring structure 保土谷化学工业株式会社 2022-07-26 CN disclosed
CN-110998889-A Organic electroluminescent element containing compound having benzoxazole ring structure 保土谷化学工业株式会社 2020-04-10 CN disclosed
CN-105968088-B Benzophenanthrene-benzofuran/benzothiophene/benzo selenophen compound of the substituent group of fused rings is formed with combination 通用显示公司 2019-06-25 CN disclosed
CN-108693009-A IDENTIFYING CANDIDATE CELLS USING IMAGE ANALYSIS 合度精密生物科技有限公司 2018-10-23 CN disclosed
EP-2385938-A1 SULFONAMIDE DERIVATIVES Pfizer Limited (GB) 2011-11-16 EP disclosed
US-8040476-B2 Display device and method of producing the same MITSUBISHI ELECTRIC CORPORATION (JP) 2011-10-18 US disclosed
CN-101817767-A Substituted sulphonamide compound and preparation method, medicine composition and application thereof SHANGHAI INST BIOL SCIENCES 2010-09-01 CN disclosed
WO-2010079443-A1 SULFONAMIDE DERIVATIVES PFIZER LIMITED (GB) 2010-07-15 WO disclosed
CN-1886844-B Electroluminescent device KONINKL PHILIPS ELECTRONICS NV 2010-06-09 CN disclosed
CN-101146889-A Luminous compound containing lanthanide ion FUJIFILM CORP (JP) 2008-03-19 CN disclosed
CN-1980892-A Dpp-IV inhibitors SANTHERA PHARMACEUTICALS CH (CH) 2007-06-13 CN disclosed
EP-1100430-A1 TRANSPARENT HAIR CONDITIONING COMPOSITION COMPRISING BREAKABLE VISIBLE PARTICLE THE PROCTER & GAMBLE COMPANY (US) 2001-05-23 EP disclosed
EP-1011615-A1 HAIR CARE COMPOSITIONS COMPRISING OPTICAL BRIGHTENERS WHICH ALTER HAIR COLORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-28 EP disclosed
WO-2000006090-A1 TRANSPARENT HAIR CONDITIONING COMPOSITION COMPRISING BREAKABLE VISIBLE PARTICLE THE PROCTER & GAMBLE COMPANY (US) 2000-02-10 WO disclosed
WO-1999013845-A1 HAIR CARE COMPOSITIONS COMPRISING OPTICAL BRIGHTENERS WHICH ALTER HAIR COLORS THE PROCTER & GAMBLE COMPANY (US) 1999-03-25 WO disclosed
WO-1999013850-A1 HAIR CARE COMPOSITIONS COMPRISING OPTICAL BRIGHTENERS AND STABILITY ENHANCING AGENTS THE PROCTER & GAMBLE COMPANY (US) 1999-03-25 WO disclosed
US-4254049-A ANTIINFLAMMATORY AGENTS; USED TO INHIBIT JOINT DETERIORIATION OF ARTHRITIS AMERICAN CYANAMID COMPANY (US) 1981-03-03 US disclosed